ESMO Workshop: Gender Medicine Meets Oncology

Lausanne, Switzerland - 30 Nov - 01 Dec 2018

Sex differences in efficacy and toxicity of systemic treatments are an undervalued issue in the era of precision oncology1

Gender medicine aims to improve the treatment of women as well as men. During the workshop, this concept, initially developed by cardiologists such as Marianne Legato and Vera Regitz-Zagrosek, will be presented together with examples of sex differences in disease biology and treatment outcomes from various fields of oncology. The theoretical aspects, for example of disease biology and pharmacology, will be reviewed and their implications for the field of oncology will be discussed with a multidisciplinary faculty and audience.

Aims

  • To summarise the differences in chromosomes, hormones, metabolism and the immune system between men and women.
  • To present differences in body composition between men and women, their impact on drug metabolism and differences in the pharmacology of different classes of anti-cancer drugs, as well as possible strategies for dose individualisation.
  • To present differences in disease biology and treatment outcomes in selected types of non sex-related cancers: lymphoma, gastrointestinal cancers and melanoma as examples.
  • To describe how current design and reporting of clinical trials in oncology address a potential impact of the sex of patients on all types of outcomes, as well as methodological hurdles in evaluating the impact of gender in clinical trials.
  • To discuss the consequences of all the above on research and practice in oncology with faculty and audience and elaborate a workshop report and consensus.

Download the preliminary programme

Who can apply

This workshop is aimed at interested medical oncologists and clinical researchers from all fields of oncology and related disciplines.

To apply, ESMO membership is mandatory. If you are not an ESMO member, or need to renew your membership, please visit the ESMO membership pages.

Course registration is free for all successful applications.

How to apply

Application is via an online form. During the application process you will be required to upload the following:

  • Your CV including a list of your publications
  • A motivation letter detailing your interest and any experience in the field of gender medicine, along with your ideas for future research
  • Applications will be reviewed by the Organising Committee and successful applicants will be notified of the outcome by 30 September 2018
  • If you are a young oncologist and wish to be considered for a travel grant (see below for details), a letter of recommendation from your Head of Department is also required.

Apply now!

Application deadline

Application for the workshop will close on 24 September 2018 (09:00 a.m. CEST).

What's included

All successful applicants will benefit from complimentary course registration and will be invited to attend a dinner on the 30 November at the Chateau d’Ouchy. Lunch (30/11 only) and coffee breaks are also included.

Travel grants will be available for up to five young oncologists (40 years of age or under at time of application) who are interested in participating in the workshop. The travel grants (up to a maximum value of 400 euros) are offered as a contribution to travel costs. In addition, ESMO will also offer the selected young oncologists 2 nights accommodation in Lausanne (this will be organised directly by ESMO). Reimbursements will be processed after participation in the event, and upon receipt of original travel invoices/vouchers. Please be aware that visa costs are NOT covered by the travel grant and are the participant's responsibility.

Organising Committee

  • Dorothea Wagner, Lausanne
  • B. Özdemir, Lausanne
  • G-P Dotto, Lausanne

Course venue

Centre Hospitalier Universitaire Vaudois (CHUV),
Rue du Bugnon 46,
1011 Lausanne
Switzerland

1. Özdemir BC et al. Sex Differences in Efficacy and Toxicity of Systemic Treatments: An Undervalued Issue in the Era of Precision Oncology. J Clin Oncol. 2018 Jul 13:JCO2018783290. doi: 10.1200/JCO.2018.78.3290